MHC Multimers Market

Global Mhc Multimers Market Size, Trends & Analysis - Forecasts to 2027 By Product Type (Classical MHC Multimers [MHC class I, MHC class II], Non-Classical MHC Multimers [CD1d]), By Application (Detection of Rare Antigen-specific T Cells, Detection Antigen-specific T Cells, Therapeutic Application [Stem Cell Transplantation Application, Oncology and Infectious Disease Vaccines]), By Target Type (CD8 & CD4 T Cells Target Detection, NKT Cells, T Cells, MAIT Cells Target Detection), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on April 13 2024 with the latest and most recent market numbers

Global MHC Multimers Market Size

The global MHC multimers market is projected to grow at a CAGR value of 4.8% from 2022 to 2027.

MHC multimers are largely utilized in immunodiagnostics applications where antigen and antibody reactions are utilized in the diagnosis of several diseases. The ability to pinpoint the exact areas within the body to diagnose illness development has improved due to major advancements in immunodiagnostics technologies. Also, challenging disease identification has improved as a result of the growing adoption of MHC multimer technology.

Globally, the use of MHC multimers-based diagnostics is steadily rising. Campaigns to educate the public about infectious disease indicators and prevention techniques are crucial in containing disease transmission. Therefore, there is a significant need for MHC multimers due to greater patient awareness.

Growing stem cell and T-cell research activities, increasing ease in clinical trial and treatment permit approvals, and the growing number of GMP-certified facilities are driving the market growth for MHC multimers. The desire for new and improved treatments for illnesses that affect the immunological and nervous systems has raised the need for MHC Multimers in T-cell therapy, antigen studies, and other diagnostic studies.

The primary drivers driving the global market for MHC multimers are greater untapped potential in the market for the effective management of chronic diseases and increased financing for stem cell and T cell-based research activities in developing nations.

MHC multimers are being increasingly employed in flow cytometry applications. The MHC multimers market is being driven by large research and development efforts by several key players for the creation of multicolor assays and cutting-edge analytical reagents. The market for flow cytometry has experienced rapid expansion as a result of the rising prevalence of chronic and infectious disorders. Following the outbreak of COVID-19, a large number of academic institutions and pharmaceutical firms have invested considerable amounts in research and development initiatives for the creation of novel vaccines and treatments.

The growing demand for chimeric antigen receptor T-Cell (CAR T) therapies is expected to increase focus on the advantages offered by MHC multimers. As a novel form of cancer treatment that activates the immune system to combat disease, CAR T-cell treatments have the potential to revolutionize healthcare. There are now more than 500 trials for investigational CAR T-cell treatments running in the pipeline as of 2019. The application of CAR T to solid tumors, which are present in the majority of cancer patients, is expected to further increase the demand for MHC multimer-based cancer diagnostics.

The MHC multimers market is constrained by complex manufacturing and supply chains and reimbursement challenges. The centralized manufacturing of MHC multimers, combined with low economies of scale, and high cost of these products have led to major constraints in the supply chain and are expected to hamper the growth of the market.

The high cost of setting up manufacturing, testing, and other facilities for the development of MHC multimers is also expected to restrain growth. Delays in insurance approvals and insurance guidelines’ restrictions are expected to be hurdles to the growing adoption of MHC multimers in immunodiagnostics.

global mhc multimers market

COVID-19 Impact on Global MHC Multimers Market

The COVID-19 epidemic has led to greater revenue generation among the major biopharmaceutical companies across the globe. Immunology and immunodiagnostics along with cancer diagnostics have had to take a backseat as the world focuses on containing the fallout from the pandemic's rapid disease transmission despite the fact that the outbreak has forced the revenue generated in the healthcare sector as a whole to grow dramatically. Firms in the pharmaceutical and biotechnology industries are expected to increase their spending on the creation of cutting-edge cancer treatments and diagnostics as more funding becomes available as things start to return to normal.

The market for MHC Multimers is anticipated to experience substantial expansion as a result of rising investments in vaccine development, promising treatment strategies, and new flow cytometry-based diagnostics that have raised the demand for the use of stem cells, gene therapy, and T cell-based treatments for COVID-19 applications.

Global MHC Multimers Market: By Product Type

The classical MHC multimers segment is expected to be the largest MHC multimers market segment based on the product type. The large application of classical MHC class I and MHC class II proteins in T cell analysis and increasing investment in T Cell studies have led to the domination of the classical MHC multimers segment among the various MHC multimers products.

The CD1d segment is expected to be the fastest-growing segment in the market. The growing application of CD1d molecules in the detection of NKT cells are expected to increase the demand for CD1d MHC multimers. The growing demand for cancer applications of MHC multimers is expected to increase the demand for the CD1d segment.

Global MHC Multimers Market: By Application

The detection of antigen-specific T cells segment is expected to be the largest MHC multimers market segment based on the application. Growing investment in flow cytometry for immunodiagnostics and oncology applications has led to the domination of the antigen-specific T cells segment.

The therapeutic application segment is expected to be the fastest-growing segment in the market. The rising geriatric population in developing nations and increasing expenditure on new oncology and infectious disease treatments are expected to increase the demand for the therapeutic application of MHC multimers.

Global MHC Multimers Market: By Target Type

The NKT cells segment is expected to be the largest MHC multimers market segment based on the target type. The growing number of people suffering from cancer and tumor growth, the growing geriatric population, and the rising investment in MHC multimers diagnostics and treatments in cancer research organizations and government institutes have led to the large share of the NKT cells segment.

The CD8 & CD4 T cells target detection segment is expected to be the fastest-growing segment in the market. The growing expenditure on MHC multimers for therapeutic applications is expected to result in the rapid growth of the CD8 and CD4 T cells.

asia pacific mhc multimers market

Global MHC Multimers Market: By Region

Growing investment in T cell therapies and flow cytometry diagnostics combined with increasing adoption of immunodiagnostics have been the key factors in the market's growth in North America.

The North American MHC multimers market is anticipated to be dominated by the United States. The demand for advanced immunodiagnostics such as flow cytometry is anticipated to rise as a result of the increasing number of FDA approvals for novel T cell therapy treatment methods.

However, throughout the projected period, the Asia-Pacific region is anticipated to exhibit the market's fastest growth. A significant factor in the expansion of the market in the APAC region has been the region's growing immunodiagnostics industry and growing investments in T cell research in the region.

The Asia Pacific MHC multimers market is anticipated to be dominated by China. The need for cell therapy for infectious disease diagnostics, oncology diagnostics, and chronic disorder management in China is anticipated to rise as the nation invests more money in the development of breakthrough immunodiagnostics.

Global MHC Multimers Market Share and Competitor Analysis

Immudex, Sigma-Aldrich, JPT Peptide Technologies, Creative Biolabs, ProImmune, MBL International, BioLegend, Altor BioScience Corporation, Immunaware, Bio X Cell, and Sanquin, among others, are some of the key players in the MHC multimers market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1   Research Methodology

1.1    Research Assumptions

1.2    Research Methodology

1.2.1    Estimates and Forecast Timeline

1.3    Information Procurement

1.3.1    Purchased Database

1.3.2    GME’s Internal Database

1.3.3    Primary Research

1.3.4    Secondary Sources & Third-Party Perspectives

            1.3.4.1    Company Information Sources

            1.3.4.2    Secondary Data Sources

1.4    Information or Data Analysis

1.4.1    Data Analysis Models

1.5    Market Formulation & Data Visualization

1.6    Data Validation & Publishing

1.7    Market Model

1.7.1    Model Details

            1.7.1.1   Top-Down Approach

            1.7.1.2   Bottom-Up Approach

1.8    Market Segmentation & Scope

1.9    Market Definition

Chapter 2   Executive Summary

2.1    Global Market Outlook

2.2     Application Outlook

2.3     Product Type Outlook

2.4     Target Type Outlook

2.5    Regional Outlook

Chapter 3   Global MHC Multimers Market Trend Analysis

3.1.    Market Introduction

3.2     Penetration & Growth Prospect Mapping

3.3     Impact of COVID-19 on the MHC Multimers Market

3.4     Metric Data based on the industry

3.5     Market Dynamic Analysis

3.5.1   Market Driver Analysis

3.5.2   Market Restraint Analysis

3.5.3   Industry Challenges

3.5.4   Industry Opportunities

3.6     Porter’s Five Analysis

3.6.1   Supplier Power

3.6.2   Buyer Power

3.6.3   Substitution Threat

3.6.4   Threat from New Entrant

3.7     Market Entry Strategies

Chapter 4   MHC Multimers Market: By Application Trend Analysis

4.1   By Application: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

4.2    Detection of Rare Antigen-specific T Cells

4.2.1    Market Estimates & Forecast Analysis of Detection of Rare Antigen-specific T Cells Segment, By Region, 2019-2027 (USD Billion)

4.3    Detection Antigen-specific T Cells 

4.3.1    Market Estimates & Forecast Analysis of Detection Antigen-specific T Cells  Segment, By Region, 2019-2027 (USD Billion)

4.4    Therapeutic Application

4.4.1    Market Estimates & Forecast Analysis of Therapeutic Application Segment, By Region, 2019-2027 (USD Billion)

Chapter 5   MHC Multimers Market: By Target Type Trend Analysis

5.1   By Target Type: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

5.2    CD8 & CD4 T Cells Target Detection

5.2.1    Market Estimates & Forecast Analysis of CD8 & CD4 T Cells Target Detection, By Region, 2019-2027 (USD Billion)

5.3    NKT Cells

5.3.1    Market Estimates & Forecast Analysis of NKT Cells Market Segment, By Region, 2019-2027 (USD Billion)

5.4    Γδ T Cells

5.4.1    Market Estimates & Forecast Analysis of Γδ T Cells Segment, By Region, 2019-2027 (USD Billion)

5.3    MAIT Cells Target Detection

5.3.1    Market Estimates & Forecast Analysis of MAIT Cells Target Detection Market Segment, By Region, 2019-2027 (USD Billion)

Chapter 6   MHC Multimers Market: By Product Type Trend Analysis

6.1   By Product Type: Historic Data vs. Forecast Data Analysis, 2022 vs. 2027

6.2    Classical MHC Multimers

6.2.1    Market Estimates & Forecast Analysis of Classical MHC Multimers Segment, By Region, 2019-2027 (USD Billion)

6.3    Non Classical MHC Multimers

6.3.1    Market Estimates & Forecast Analysis of Non Classical MHC Multimers Segment, By Region, 2019-2027 (USD Billion)

Chapter 7   MHC Multimers Market, By Region

7.1    Regional Outlook

7.2    North America

7.2.1    Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.2.2    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.2.3    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.2.4    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.2.5    U.S.

7.2.5.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.2.5.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.2.5.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.2.6    Canada

7.2.6.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.2.6.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.2.6.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.5.7    Mexico

7.5.5.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.5.5.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.5.5.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.3    Europe

7.3.1    Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.3.2    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.3.3    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.3.4    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.3.5    Germany

7.3.5.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.3.5.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.3.5.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.3.6    UK

7.3.6.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.3.6.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.3.6.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.3.7    France

7.3.7.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.3.7.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.3.7.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.3.8    Russia

7.3.8.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.3.8.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.3.8.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.3.9    Italy

7.3.9.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.3.9.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.3.9.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.3.10    Spain

7.3.10.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.3.10.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.3.10.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.3.11    Netherlands

7.3.11.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.3.11.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.3.11.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.3.12    Rest of Europe

7.3.12.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.3.12.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.3.12.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4    Asia Pacific

7.4.1    Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.4.2    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.3    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.4    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4.5    China

7.4.5.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.5.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.5.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4.6    India

7.4.6.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.6.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.6.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4.7    Japan

7.4.7.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.7.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.7.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4.8    South Korea

7.4.8.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.8.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.8.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4.9    Thailand

7.4.9.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.9.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.9.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4.10    Indonesia

7.4.10.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.10.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.10.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4.11    Malaysia

7.4.11.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.11.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.11.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4.12    Singapore

7.4.12.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.12.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.12.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4.13    Vietnam

7.4.13.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.13.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.13.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.4.14    Rest of Asia Pacific

7.4.14.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.4.14.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.4.14.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.5    Central & South America

7.5.1    Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.5.2    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.5.3    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.5.4   Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.5.5    Brazil

7.5.5.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.5.5.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.5.5.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.5.6    Argentina

7.5.6.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.5.6.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.5.6.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.5.7    Chile

7.5.7.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.5.7.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.5.7.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.5.8    Rest of Central & South America

7.5.8.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.5.8.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.5.8.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.6    Middle East & Africa

7.6.1    Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.6.2    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.6.3    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.6.4    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.6.5    Saudi Arabia

7.6.5.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.6.5.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.6.5.3   Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.6.6    United Arab Emirates

7.6.6.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.6.6.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.6.6.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.6.7    South Africa

7.6.7.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.6.7.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.6.7.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.6.8    Israel

7.6.8.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.6.8.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.6.8.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

7.5.9    Rest of Middle East & Africa

7.5.9.1    Market Estimates & Forecast Analysis, By Application, 2019-2027 (USD Billion)

7.5.9.2    Market Estimates & Forecast Analysis, By Target Type, 2019-2027 (USD Billion)

7.5.9.3    Market Estimates & Forecast Analysis, By Product Type, 2019-2027 (USD Billion)

Chapter 8   Competitive Analysis

8.1    Key Global Players, Recent Developments & their Impact on the Industry

8.2    Four Quadrant Competitor Positioning Matrix

8.2.1    Key Innovators

8.2.2    Market Leaders

8.2.3    Emerging Players

8.2.4    Market Challengers

8.3    Vendor Landscape Analysis

8.4    End-User Landscape Analysis

8.5    Company Market Share Analysis, 2021

Chapter 9   Company Profile Analysis

9.1    Immudex

9.1.1    Company Overview

9.1.2    Financial Analysis

9.1.3    Strategic Initiatives

9.1.4    Product Benchmarking

9.2     Sigma-Aldrich

9.2.1    Company Overview

9.2.2    Financial Analysis

9.2.3    Strategic Initiatives

9.2.4    Product Benchmarking

9.3     Creative Biolabs

9.3.1    Company Overview

9.3.2    Financial Analysis

9.3.3    Strategic Initiatives

9.3.4    Product Benchmarking

9.4    Adaptimmune Ltd

9.4.1    Company Overview

9.4.2    Financial Analysis

9.4.3    Strategic Initiatives

9.4.4    Product Benchmarking

9.5    ProImmune

9.5.1    Company Overview

9.5.2    Financial Analysis

9.5.3    Strategic Initiatives

9.5.4    Product Benchmarking

9.6     MBL International

9.6.1    Company Overview

9.6.2    Financial Analysis

9.6.3    Strategic Initiatives

9.6.4    Product Benchmarking

9.7     BioLegend 

9.7.1    Company Overview

9.7.2    Financial Analysis

9.7.3    Strategic Initiatives

9.7.4    Product Benchmarking

9.8    Altor BioScience Corporation 

9.8.1    Company Overview

9.8.2    Financial Analysis

9.8.3    Strategic Initiatives

9.8.4    Product Benchmarking

9.9     Immunaware 

9.9.1    Company Overview

9.9.2    Financial Analysis

9.9.3    Strategic Initiatives

9.9.4    Product Benchmarking

9.10   Bio X Cell 

9.10.1    Company Overview

9.10.2    Financial Analysis

9.10.3    Strategic Initiatives

9.10.4    Product Benchmarking

9.11   Other Companies

9.11.1    Company Overview

9.11.2    Financial Analysis

9.11.3    Strategic Initiatives

9.11.4    Product Benchmarking

List of Tables

1 Technological Advancements in MHC Multimers Market

2 Global MHC Multimers Market: Key Market Drivers

3 Global MHC Multimers Market: Key Market Challenges

4 Global MHC Multimers Market: Key Market Opportunities

5 Global MHC Multimers Market: Key Market Restraints

6 Global MHC Multimers Market Estimates & Forecast Analysis, 2019-2027 (USD Billion)

7 Global MHC Multimers Market, By Application, 2019-2027 (USD Billion)

8 Detection of Rare Antigen-specific T Cells: Global MHC Multimers Market, By Region, 2019-2027 (USD Billion)

9 Detection Antigen-specific T Cells: Global MHC Multimers Market, By Region, 2019-2027 (USD Billion)

10 Therapeutic Application: Global MHC Multimers Market, By Region, 2019-2027 (USD Billion)

11 Global MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

12 CD8 & CD4 T Cells Target Detection: Global MHC Multimers Market, By Region, 2019-2027 (USD Billion)

13 Γδ T Cells: Global MHC Multimers Market, By Region, 2019-2027 (USD Billion)

14 NKT Cells: Global MHC Multimers Market, By Region, 2019-2027 (USD Billion)

15 MAIT Cells Target Detection: Global MHC Multimers Market, By Region, 2019-2027 (USD Billion)

16 Global MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

17 Classical MHC Multimers: Global MHC Multimers Market, By Region, 2019-2027 (USD Billion)

18 Non Classical MHC Multimers: Global MHC Multimers Market, By Region, 2019-2027 (USD Billion)

19 Regional Analysis: Global MHC Multimers Market, By Region, 2019-2027 (USD Billion)

20 North America: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

21 North America: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

22 North America: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

23 North America: MHC Multimers Market, By Country, 2019-2027 (USD Billion)

24 U.S: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

25 U.S: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

26 U.S: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

27 Canada: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

28 Canada: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

29 Canada: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

30 Mexico: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

31 Mexico: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

32 Mexico: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

33 Rest of North America: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

34 Rest of North America: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

35 Rest of North America: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

36 Europe: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

37 Europe: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

38 Europe: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

39 Europe: MHC Multimers Market, By Country, 2019-2027 (USD Billion)

40 Germany: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

41 Germany: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

42 Germany: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

43 UK: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

44 UK: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

45 UK: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

46 France: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

47 France: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

48 France: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

49 Italy: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

50 Italy: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

51 Italy: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

52 Spain: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

53 Spain: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

54 Spain: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

55 Netherlands: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

56 Netherlands: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

57 Netherlands: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

58 Rest Of Europe: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

59 Rest Of Europe: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

60 Rest Of Europe: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

61 Asia Pacific: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

62 Asia Pacific: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

63 Asia Pacific: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

64 Asia Pacific: MHC Multimers Market, By Country, 2019-2027 (USD Billion)

65 China: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

66 China: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

67 China: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

68 India: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

69 India: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

70 India: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

71 Japan: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

72 Japan: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

73 Japan: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

74 South Korea: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

75 South Korea: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

76 South Korea: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

77 Thailand: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

78 Thailand: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

79 Thailand: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

80 Indonesia: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

81 Indonesia: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

82 Indonesia: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

83 Malaysia: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

84 Malaysia: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

85 Malaysia: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

86 Singapore: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

87 Singapore: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

88 Singapore: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

89 Vietnam: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

90 Vietnam: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

91 Vietnam: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

92 Rest of APAC: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

93 Rest of APAC: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

94 Rest of APAC: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

95 Middle East & Africa: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

96 Middle East & Africa: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

97 Middle East & Africa: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

98 Middle East & Africa: MHC Multimers Market, By Country, 2019-2027 (USD Billion)

99 Saudi Arabia: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

100 Saudi Arabia: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

101 Saudi Arabia: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

102 UAE: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

103 UAE: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

104 UAE: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

105 Israel: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

106 Israel: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

107 Israel: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

108 South Africa: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

109 South Africa: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

110 South Africa: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

111 Rest of MEA: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

112 Rest of MEA: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

113 Rest of MEA: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

114 Central & South America: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

115 Central & South America: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

116 Central & South America: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

117 Central & South America: MHC Multimers Market, By Country, 2019-2027 (USD Billion)

118 Brazil: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

119 Brazil: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

120 Brazil: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

121 Chile: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

122 Chile: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

123 Chile: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

124 Argentina: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

125 Argentina: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

126 Argentina: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

127 Rest of CSA: MHC Multimers Market, By Application, 2019-2027 (USD Billion)

128 Rest of CSA: MHC Multimers Market, By Target Type, 2019-2027 (USD Billion)

129 Rest of CSA: MHC Multimers Market, By Product Type, 2019-2027 (USD Billion)

130 Immudex: Products Offered

131 Sigma-Aldrich: Products Offered

132 Creative Biolabs: Products Offered

133 Adaptimmune Ltd: Products Offered

134 ProImmune: Products Offered

135 MBL International: Products Offered

136 Immunaware: Products Offered

137 BioLegend: Products Offered

138 Altor BioScience Corporation: Products Offered

139 Other Companies: Products Offered

140 Bio X Cell: Products Offered

List of Figures

1. Global MHC Multimers Market Segmentation & Research Scope

2. Primary Research Partners and Local Informers

3. Primary Research Process

4. Primary Research Approaches

5. Primary Research Responses

6. Global MHC Multimers Market: Penetration & Growth Prospect Mapping

7. Global MHC Multimers Market: Value Chain Analysis

8. Global MHC Multimers Market Drivers

9. Global MHC Multimers Market Restraints

10. Global MHC Multimers Market Opportunities

11. Global MHC Multimers Market Challenges

12. Key MHC Multimers Market Manufacturer Analysis

13. Global MHC Multimers Market: Porter’s Five Forces Analysis

14. PESTLE Analysis & Impact Analysis

15. Immudex: Company Snapshot

16. Immudex: Swot Analysis

17. Sigma-Aldrich: Company Snapshot

18. Sigma-Aldrich: Swot Analysis

19. Creative Biolabs: Company Snapshot

20. Creative Biolabs: Swot Analysis

21. JPT Peptide Technologies: Company Snapshot

22. JPT Peptide Technologies: Swot Analysis

23. ProImmune: Company Snapshot

24. ProImmune: Swot Analysis

25. Immunaware: Company Snapshot

26. Immunaware: Swot Analysis

27. BioLegend: Company Snapshot

28. BioLegend: Swot Analysis

29. Altor BioScience Corporation: Company Snapshot

30. Altor BioScience Corporation: Swot Analysis

31. MBL International: Company Snapshot

32. MBL International: Swot Analysis

33. Bio X Cell: Company Snapshot

34. Bio X Cell: Swot Analysis

35. Other Companies: Company Snapshot

36. Other Companies: SWOT Analysis 

The Global MHC Multimers Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the MHC Multimers Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The global MHC multimers market is projected to grow at a CAGR value of 4.8% from 2022 to 2027.
Immudex, Sigma-Aldrich, JPT Peptide Technologies, Creative Biolabs, ProImmune, MBL International, BioLegend, Altor BioScience Corporation, Immunaware, Bio X Cell, and Sanquin, among others, are the some of the key players in the MHC multimers market.
The market for MHC Multimers is anticipated to experience substantial expansion as a result of rising investments in vaccine development, promising treatment strategies, and new flow cytometry-based diagnostics that have raised the demand for the use of stem cells, gene therapy, and T cell-based treatments for COVID-19 applications.
The growing investment in the development of novel gene therapy-based cancer treatments, the growing availability of cell therapy in the market, the growing investment in T-cell therapies, and technological advancements in immunodiagnostic technologies are the major drivers of the MHC multimers market.
The North American MHC multimers market is anticipated to be dominated by the United States. The demand for advanced immunodiagnostics such as flow cytometry is anticipated to rise as a result of the increasing number of FDA approvals for novel T cell therapy treatment methods.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius